Back
Revance Therapeutics Vs. Ligand Pharmaceuticals Industry Stock Comparison
Sell
13
RVNC
Revance Therapeutics
Last Price:
$3.09
Seasonality Move:
-2.77%
Sell
50
LGND
Ligand Pharmaceuticals
Last Price:
$115.00
Seasonality Move:
9.17%
Sell
13
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy, Sell or Hold?
-
The current Revance Therapeutics [RVNC] share price is $3.08. The Score for RVNC is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
-
RVNC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
50
Ligand Pharmaceuticals (LGND)
is a Sell
Is Ligand Pharmaceuticals a Buy, Sell or Hold?
-
The current Ligand Pharmaceuticals [LGND] share price is $114.58. The Score for LGND is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
LGND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RVNC Stock Price Chart
What is Revance Therapeutics's stock price today?
-
The Revance Therapeutics share price today is $3.08The current trend is relatively stagnant and RVNC is experiencing slight buying pressure.
LGND Stock Price Chart
What is Ligand Pharmaceuticals's stock price today?
-
The Ligand Pharmaceuticals share price today is $114.58The current trend is moderately bearish and LGND is experiencing buying pressure, which is a positive indicator for future bullish movement.
RVNC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.38 | Sell |
Relative Strength Index (14 RSI): | 33.1 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.14 - 3.96) | Sell |
Bollinger Bands (100): | (3.74 - 6.28) | Sell |
LGND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 46.42 | Sell |
Chaikin Money Flow: | 318170 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (113.95 - 122.43) | Sell |
Bollinger Bands (100): | (100.49 - 116.81) | Buy |
RVNC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.07 | Buy |
20-day SMA: | 3.46 | Sell |
50-day SMA: | 4.37 | Sell |
200-day SMA: | 4.37 | Sell |
8-day EMA: | 3.14 | Sell |
20-day EMA: | 3.46 | Sell |
50-day EMA: | 4.1 | Sell |
200-day EMA: | 5.56 | Sell |
LGND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 117.05 | Sell |
20-day SMA: | 119.57 | Sell |
50-day SMA: | 114.96 | Sell |
200-day SMA: | 95.37 | Buy |
8-day EMA: | 116.76 | Sell |
20-day EMA: | 117.7 | Sell |
50-day EMA: | 114.77 | Sell |
200-day EMA: | 98.95 | Buy |
Revance Therapeutics Earnings Growth & RVNC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.38 per share, and an increase next year of $0.63 per share.
Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and an increase next year of $0.52 per share.
Revance Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ligand Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |